The University of Chicago Header Logo

Testing the wrong hypothesis in phase II oncology trials: there is a better alternative.

Testing the wrong hypothesis in phase II oncology trials: there is a better alternative. Clin Cancer Res. 2007 Feb 01; 13(3):781-2.

View in: PubMed